类风湿-话题@MedSci

#类风湿#

751篇内容 | 7481人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1334210, encodeId=33a3133421059, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=【盘点】类风湿性关节炎近期治疗新进展, objectType=article, longId=189033, objectId=908718903332, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=908718903332, replyNumber=0, likeNumber=62, createdTime=2020-03-02, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=908718903332, moduleTitle=【盘点】类风湿性关节炎近期治疗新进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=908718903332)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334209, encodeId=c8ce1334209f9, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=Arthritis Rheumatol：两个早期类风湿性关节炎队列实施不同靶向治疗策略达到缓解的情况, objectType=article, longId=189029, objectId=b5d61890294c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5d61890294c, replyNumber=0, likeNumber=124, createdTime=2020-03-02, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5d61890294c, moduleTitle=Arthritis Rheumatol：两个早期类风湿性关节炎队列实施不同靶向治疗策略达到缓解的情况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5d61890294c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334208, encodeId=a18c1334208aa, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=Ann Rheum Dis：血清代谢组和脂质组差异确定了血清阴性类风湿性关节炎vs银屑病关节炎的潜在生物标志物, objectType=article, longId=188887, objectId=a40518888e08, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a40518888e08, replyNumber=0, likeNumber=90, createdTime=2020-02-29, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a40518888e08, moduleTitle=Ann Rheum Dis：血清代谢组和脂质组差异确定了血清阴性类风湿性关节炎vs银屑病关节炎的潜在生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a40518888e08)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334207, encodeId=e1e4133420e25, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=Ann Rheum Dis：类风湿性关节炎靶向治疗真有效吗？患者队列纵向分析（RA BIODAM）, objectType=article, longId=188886, objectId=2db218888685, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2db218888685, replyNumber=0, likeNumber=79, createdTime=2020-02-29, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2db218888685, moduleTitle=Ann Rheum Dis：类风湿性关节炎靶向治疗真有效吗？患者队列纵向分析（RA BIODAM）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2db218888685)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334206, encodeId=9ed51334206a7, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=Ann Rheum Dis：类风湿性关节炎的流行病学正在改变吗？1985-2014年人群发病率研究结果, objectType=article, longId=188408, objectId=a1b41884087a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a1b41884087a, replyNumber=0, likeNumber=56, createdTime=2020-02-21, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a1b41884087a, moduleTitle=Ann Rheum Dis：类风湿性关节炎的流行病学正在改变吗？1985-2014年人群发病率研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a1b41884087a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334205, encodeId=f715133420567, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=Lancet通讯文章：应对新冠肺炎，抗类风湿药物巴瑞替尼或有效！, objectType=article, longId=187997, objectId=9caf18e9972a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9caf18e9972a, replyNumber=0, likeNumber=50, createdTime=2020-02-15, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9caf18e9972a, moduleTitle=Lancet通讯文章：应对新冠肺炎，抗类风湿药物巴瑞替尼或有效！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9caf18e9972a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334204, encodeId=88651334204a1, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=CLIN CHEM LAB MED：血清钙蛋白作为类风湿关节炎生物标志物的分析前和分析混杂物分析, objectType=article, longId=187926, objectId=b4ed18e9261a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4ed18e9261a, replyNumber=0, likeNumber=73, createdTime=2020-02-14, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4ed18e9261a, moduleTitle=CLIN CHEM LAB MED：血清钙蛋白作为类风湿关节炎生物标志物的分析前和分析混杂物分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4ed18e9261a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334203, encodeId=bbf913342035c, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=2019 EULAR建议：应用合成或生物类改善病情抗风湿药治疗类风湿性关节炎, objectType=article, longId=187487, objectId=545318e487a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=545318e487a7, replyNumber=0, likeNumber=11, createdTime=2020-02-06, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=545318e487a7, moduleTitle=2019 EULAR建议：应用合成或生物类改善病情抗风湿药治疗类风湿性关节炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=545318e487a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334202, encodeId=c63c1334202b3, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=J Rheumatol：IL-17A和IL-17F在类风湿性关节炎和外周型脊椎关节炎中的表达及功能反应, objectType=article, longId=186528, objectId=ba8f18652830, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba8f18652830, replyNumber=0, likeNumber=66, createdTime=2020-01-21, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba8f18652830, moduleTitle=J Rheumatol：IL-17A和IL-17F在类风湿性关节炎和外周型脊椎关节炎中的表达及功能反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba8f18652830)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334201, encodeId=bc6a133420189, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=J Rheumatol：托珠单抗对类风湿性关节炎的疗效不受合并症或肥胖的影响, objectType=article, longId=186487, objectId=d18c18648edb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d18c18648edb, replyNumber=0, likeNumber=80, createdTime=2020-01-20, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d18c18648edb, moduleTitle=J Rheumatol：托珠单抗对类风湿性关节炎的疗效不受合并症或肥胖的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d18c18648edb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334200, encodeId=97ea1334200ae, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=J Rheumatol：类风湿性关节炎患者骨质疏松症治疗指南的实施效果评估, objectType=article, longId=186320, objectId=118618632081, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=118618632081, replyNumber=0, likeNumber=77, createdTime=2020-01-17, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=118618632081, moduleTitle=J Rheumatol：类风湿性关节炎患者骨质疏松症治疗指南的实施效果评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=118618632081)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334199, encodeId=84f213341997a, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=PLos One：康复频率对类风湿性关节炎患者卒中风险的影响, objectType=article, longId=186319, objectId=45ba1863199a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=45ba1863199a, replyNumber=0, likeNumber=94, createdTime=2020-01-17, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45ba1863199a, moduleTitle=PLos One：康复频率对类风湿性关节炎患者卒中风险的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=45ba1863199a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334198, encodeId=f0d2133419855, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=J Rheumatol：类风湿性关节炎临床试验中的安慰剂反应, objectType=article, longId=186267, objectId=a8e218626e3f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8e218626e3f, replyNumber=0, likeNumber=59, createdTime=2020-01-16, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8e218626e3f, moduleTitle=J Rheumatol：类风湿性关节炎临床试验中的安慰剂反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a8e218626e3f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334197, encodeId=a031133419ef6, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=PLos One：类风湿性关节炎患者生物类改善病情抗风湿药降级的成本-疗效分析, objectType=article, longId=186215, objectId=23e8186215e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=23e8186215e9, replyNumber=0, likeNumber=63, createdTime=2020-01-15, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=23e8186215e9, moduleTitle=PLos One：类风湿性关节炎患者生物类改善病情抗风湿药降级的成本-疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=23e8186215e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334196, encodeId=65961334196b7, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=Clin Exp Rheumatol：类风湿性关节炎自身抗体水平与疾病活动性的关联取决于基线炎症, objectType=article, longId=186127, objectId=4bd218612e59, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4bd218612e59, replyNumber=0, likeNumber=70, createdTime=2020-01-14, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4bd218612e59, moduleTitle=Clin Exp Rheumatol：类风湿性关节炎自身抗体水平与疾病活动性的关联取决于基线炎症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4bd218612e59)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334195, encodeId=3a91133419519, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=Clin Exp Rheumatol：在国际多中心研究中对类风湿性关节炎的新分类标准进行验证, objectType=article, longId=186034, objectId=31e81860342c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31e81860342c, replyNumber=0, likeNumber=74, createdTime=2020-01-12, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31e81860342c, moduleTitle=Clin Exp Rheumatol：在国际多中心研究中对类风湿性关节炎的新分类标准进行验证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31e81860342c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334194, encodeId=acf713341941f, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=艾伯维的口服JAK抑制剂RINVOQ获得加拿大批准，用于治疗中度至重度活动性类风湿性关节炎, objectType=article, longId=185935, objectId=6a1818593535, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a1818593535, replyNumber=0, likeNumber=92, createdTime=2020-01-10, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a1818593535, moduleTitle=艾伯维的口服JAK抑制剂RINVOQ获得加拿大批准，用于治疗中度至重度活动性类风湿性关节炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a1818593535)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334193, encodeId=3e09133419313, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=Semin Arthritis Rheu：类风湿性关节炎患者开始和停止阿片类药物治疗的相关因素, objectType=article, longId=185924, objectId=ba7518592435, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba7518592435, replyNumber=0, likeNumber=76, createdTime=2020-01-10, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba7518592435, moduleTitle=Semin Arthritis Rheu：类风湿性关节炎患者开始和停止阿片类药物治疗的相关因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba7518592435)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334192, encodeId=a1cf133419286, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=Semin Arthritis Rheu：类风湿性关节炎中性粒细胞-淋巴细胞比率及其预测三联疗法失败的能力, objectType=article, longId=185923, objectId=73c11859238f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73c11859238f, replyNumber=0, likeNumber=64, createdTime=2020-01-10, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73c11859238f, moduleTitle=Semin Arthritis Rheu：类风湿性关节炎中性粒细胞-淋巴细胞比率及其预测三联疗法失败的能力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73c11859238f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334191, encodeId=37d71334191e9, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=Ann Rheum Dis：NI-0101对甲氨蝶呤反应不足类风湿性关节炎患者的疗效和安全性, objectType=article, longId=185740, objectId=b523185e4089, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b523185e4089, replyNumber=0, likeNumber=61, createdTime=2020-01-07, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b523185e4089, moduleTitle=Ann Rheum Dis：NI-0101对甲氨蝶呤反应不足类风湿性关节炎患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b523185e4089)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

类风湿

2020-05-29

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

【盘点】类风湿性关节炎近期治疗新进展

2020-03-02

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

Arthritis Rheumatol：两个早期类风湿性关节炎队列实施不同靶向治疗策略达到缓解的情况

2020-03-02

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

Ann Rheum Dis：血清代谢组和脂质组差异确定了血清阴性类风湿性关节炎vs银屑病关节炎的潜在生物标志物

2020-02-29

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

Ann Rheum Dis：类风湿性关节炎靶向治疗真有效吗？患者队列纵向分析（RA BIODAM）

2020-02-29

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

Ann Rheum Dis：类风湿性关节炎的流行病学正在改变吗？1985-2014年人群发病率研究结果

2020-02-21

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

Lancet通讯文章：应对新冠肺炎，抗类风湿药物巴瑞替尼或有效！

2020-02-15

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

CLIN CHEM LAB MED：血清钙蛋白作为类风湿关节炎生物标志物的分析前和分析混杂物分析

2020-02-14

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

2019 EULAR建议：应用合成或生物类改善病情抗风湿药治疗类风湿性关节炎

2020-02-06

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

J Rheumatol：IL-17A和IL-17F在类风湿性关节炎和外周型脊椎关节炎中的表达及功能反应

2020-01-21

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

J Rheumatol：托珠单抗对类风湿性关节炎的疗效不受合并症或肥胖的影响

2020-01-20

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

J Rheumatol：类风湿性关节炎患者骨质疏松症治疗指南的实施效果评估

2020-01-17

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

PLos One：康复频率对类风湿性关节炎患者卒中风险的影响

2020-01-17

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

J Rheumatol：类风湿性关节炎临床试验中的安慰剂反应

2020-01-16

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

PLos One：类风湿性关节炎患者生物类改善病情抗风湿药降级的成本-疗效分析

2020-01-15

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

Clin Exp Rheumatol：类风湿性关节炎自身抗体水平与疾病活动性的关联取决于基线炎症

2020-01-14

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

Clin Exp Rheumatol：在国际多中心研究中对类风湿性关节炎的新分类标准进行验证

2020-01-12

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

艾伯维的口服JAK抑制剂RINVOQ获得加拿大批准，用于治疗中度至重度活动性类风湿性关节炎

2020-01-10

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

Semin Arthritis Rheu：类风湿性关节炎患者开始和停止阿片类药物治疗的相关因素

2020-01-10

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

Semin Arthritis Rheu：类风湿性关节炎中性粒细胞-淋巴细胞比率及其预测三联疗法失败的能力

2020-01-10

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

Ann Rheum Dis：NI-0101对甲氨蝶呤反应不足类风湿性关节炎患者的疗效和安全性

2020-01-07

科室
- - 订阅+
  - 更多科室
工具
服务